Dinaciclib Completed Phase 2 Trials for Breast Neoplasms / Non-Small Cell Lung Carcinoma Treatment

Indications	Status	Purpose	Phase
DBCOND0028011 (Breast Neoplasms) DBCOND0030527 (Non-Small Cell Lung Carcinoma)	Completed	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT00732810	SCH 727965 in Patients With Advanced Breast and Lung Cancers (Study P04716)	Capecitabine (DB01101) Dinaciclib (DB12021) Erlotinib (DB00530)